ChemicalBook >> CAS DataBase List >>GSK2636771

GSK2636771

CAS No.
1372540-25-4
Chemical Name:
GSK2636771
Synonyms
CS-357;GSK2636771;GSK 2636771B;GSK2636771cas;GSK2636771 USP/EP/BP;GSK2636771/GSK-2636771;GSK 2636771 dihydrochloride;PI3Kβ-selective inhibitor GS2636771;2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic;2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
CBNumber:
CB52624179
Molecular Formula:
C22H22F3N3O3
Molecular Weight:
433.42
MDL Number:
MFCD22417098
MOL File:
1372540-25-4.mol
MSDS File:
SDS
Last updated:2024-04-24 09:01:11

GSK2636771 Properties

Melting point >225°C (dec.)
Boiling point 641.3±55.0 °C(Predicted)
Density 1.38
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
pka -2.70±0.30(Predicted)
form Solid
color Pale Yellow
InChI InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)
InChIKey XTKLTGBKIDQGQL-UHFFFAOYSA-N
SMILES C1(C)N(CC2=CC=CC(C(F)(F)F)=C2C)C2=CC(N3CCOCC3)=CC(C(O)=O)=C2N=1
FDA UNII DW94IAT0LS

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

GSK2636771 price More Price(36)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 17380 GSK2636771 ≥98% 1372540-25-4 500μg $44 2024-03-01 Buy
Cayman Chemical 17380 GSK2636771 ≥98% 1372540-25-4 1mg $74 2024-03-01 Buy
Cayman Chemical 17380 GSK2636771 ≥98% 1372540-25-4 5mg $278 2024-03-01 Buy
Cayman Chemical 17380 GSK2636771 ≥98% 1372540-25-4 10mg $384 2024-03-01 Buy
Usbiological 451491 GSK2636771 1372540-25-4 2.5mg $403 2021-12-16 Buy
Product number Packaging Price Buy
17380 500μg $44 Buy
17380 1mg $74 Buy
17380 5mg $278 Buy
17380 10mg $384 Buy
451491 2.5mg $403 Buy

GSK2636771 Chemical Properties,Uses,Production

Description

GSK2636771 is a potent, orally bioavailable, adenosine triphosphate-competitive, selective inhibitor of PI3Kβ with an apparent Ki value of 0.89 nmol/L (IC50 = 5.2 nmol/L), >900-fold selectivity over p110α and p110γ, and >10-fold selectivity over p110δ isoforms, while sparing other PI3K superfamily kinases[1-2].

Uses

GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines.

in vitro

GSK-2636771 shows selectively inhibitory activity in PTEN null cell lines (human prostate adenocarcinoma PC-3 and breast cancer HCC70) with EC50 of 36 nM and 72 nM, respectively. GSK2636771 significantly decreases cell viability in p110β-reliant PTEN-deficient PC3 prostate and BT549 and HCC70 breast cancer cell lines. It leads to a marked decrease of AKT phosphorylation only in the control prostate and breast cancer cell lines.

References

[1] Mateo, Joaquin , et al. "A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors." Clinical Cancer Research (2017):clincanres.0725.2017.
[2] Sarker, Debashis , et al. "A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer." Clinical Cancer Research 27.19(2021):5248-5257.

GSK2636771 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 143)Suppliers
Supplier Tel Email Country ProdList Advantage
Hubei Chuchang Biotech Co., Ltd.
+86-18727130788 +86-18727130788 info@chuchangbiotech.com China 100 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Changzhou PBpharmaceutical R&D Co.,Ltd
0519-83990708 info@pbpharm.com CHINA 498 58
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29271 58

View Lastest Price from GSK2636771 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
GSK-2636771 pictures 2024-04-19 GSK-2636771
1372540-25-4
US $0.00-0.00 / mg 1mg 98% 20G Hubei Chuchang Biotech Co., Ltd.
GSK2636771 pictures 2022-10-14 GSK2636771
1372540-25-4
US $0.00-0.00 / KG 1KG 98% 1Ton Henan Aochuang Chemical Co.,Ltd.
GSK2636771 pictures 2019-07-06 GSK2636771
1372540-25-4
US $2.00 / kg 1kg 99% 100kg Career Henan Chemical Co
  • GSK-2636771 pictures
  • GSK-2636771
    1372540-25-4
  • US $0.00-0.00 / mg
  • 98%
  • Hubei Chuchang Biotech Co., Ltd.
  • GSK2636771 pictures
  • GSK2636771
    1372540-25-4
  • US $0.00-0.00 / KG
  • 98%
  • Henan Aochuang Chemical Co.,Ltd.
  • GSK2636771 pictures
  • GSK2636771
    1372540-25-4
  • US $2.00 / kg
  • 99%
  • Career Henan Chemical Co

GSK2636771 Spectrum

GSK2636771 2-Methyl-1-[[2-Methyl-3-(trifluoroMethyl)phenyl]Methyl]-6-(4-Morpholinyl)-1H-benziMidazole-4-carboxylic acid GSK2636771/GSK-2636771 GSK 2636771 dihydrochloride 2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic 1H-Benzimidazole-4-carboxylic acid, 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)- 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid GSK2636771 2-METHYL-1-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]METHYL]-6-MORPHOLIN-4-YLBENZIMIDAZOLE-4-CARBOXYLIC ACID 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(morpholin-4-yl)-1H-1,3-benzodiazole-4-carboxylic acid CS-357 PI3Kβ-selective inhibitor GS2636771 GSK 2636771B GSK2636771 USP/EP/BP GSK2636771cas 2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid 1372540-25-4 Inhibitors PI3K/Akt/mTOR Akt mTOR PI3K api 1372540-25-4